Amir Mekhail, BPharm
President and Marketing Lead
Amir Mekhail (founder of IHS) has 25+ years of global experience in nutrition marketing, sales and general management in more than 20 countries including the Middle East, North East Africa & United States. Throughout his career, he managed a range of infant nutrition business initiatives valued up to $40M USD in sales. He also carried out successful launches of new concepts & products into the multi-million dollar infant nutrition markets.
As part of his role, Mr. Mekhail initiated & implemented successful medical channel activation strategies driven by establishing value-added partnerships with leading healthcare accounts, and creating shared values for their patients and communities.
He also organized over 40 impactful medical/scientific events attended by physicians, nurses, executives and academics. Mr. Mekhail is also a strong believer of value-added growth, and therefore, developed an innovation/renovation process management tool to guide new launches for sustainable market leadership.
Mina Mekhail, BEng, MESc, PhD
Vice President and Scientific Affairs Lead
Mina Mekhail (co-founder of IHS) is an adjunct professor of biomedical engineering at McGill University and an innovation consultant with 12 years of experience in research and innovation management.
During his career he successfully secured > $2M in funding from federal granting agencies (CIHR, NSERC) as well as Venture Capital. Dr. Mekhail has also demonstrated excellence in research as reflected by his 13 scientific publications in top scientific journals, 2 patents (one granted and another pending), and more than 15 awards.
He also has extensive experience in establishing and managing innovation within a hospital setting. As a project manager in a top Children's hospital in North America, he managed 11 projects including: using 3D printing for pre-surgical planning; using virtual reality to reduce patient anxiety; developing a novel medical device to improve patient healing; developing a mobile app to educate children and their families on a rare disease; and consulting clinicians regarding innovation management.